Downers Grove, IL – Coventry recently announced the release of the fourth part of its 2017 Drug Trends Series, which is based on all calendar year transactions billed through its PBM Program, First Script, as well as transactions from medical bill review to reflect the total pharmacy experience for their client base.
When releasing the previous parts of its report, Coventry noted that they are continuing to present data for traditional, managed, and unmanaged views; however, they are now sharing the information in shorter, more-condensed pieces delivered every few weeks vs. one large manuscript.
This fourth installment of the series is dedicated to topicals, specialty medications, and regulatory development. Although topicals and specialty drugs represent only 6% of total aggregate prescriptions, they account for 17.9% of total aggregate cost, thus warranting increased attention.
This final edition will share aggregate topical and specialty drug information and review the differences in cost and utilization among the managed and unmanaged views. The report also discusses the current regulatory and legislative landscape.
Key trends from this piece included:
Managed Topical Medications
- Cost per claim has decreased modestly over the last 2 years, 0.3% (2016) and 1.9% (2017).
- Utilization has fallen by at least 6% per year over the last 2 years.
- Cost per script has increased for the last 3 years, from a high of 20.9% (2015) to a low of 4.9% (2017).
Unmanaged Topical Medications
- Cost per claim has increased over the last 2 years, 9.1% (2016) and 29.4% (2017).
- Increasing utilization has occurred for the last 2 years (1.5% in 2016 and 9.8% in 2017).
- Cost per script has increased at least 7% each year spiking at 17.9% in 2017.
Managed Specialty Medications
- 7-8% increases in cost per claim per year.
- Specialty usage, although less than 1% of all scripts, has increased by at least 9% per year.
- Cost per script has experienced a 3-year downward trend (1.7% in 2017), influenced by declining use of hepatitis C medications
Unmanaged Specialty Medications
- Significant fluctuations in cost per claim trending up 22.1% in 2016 and down 22.5% in 2017.
- Specialty usage accounted for less than 2.5% of all scripts and has decreased between 2-6% per year.
- Cost per script, influenced by varying usage of medications used to treat anemia, rose 24.6% in 2016 and fell 17.8% in 2017.
View Part 4 here: Coventry 2017 First Script Drug Trends Report Series, Part 4 (PDF)
View Part 3 here: Coventry 2017 First Script Drug Trends Report Series, Part 3 (PDF)
View Part 2 here: Coventry 2017 First Script Drug Trends Report Series, Part 2 (PDF)
View Part 1 here: Coventry 2017 First Script Drug Trends Report Series, Part 1 (PDF)
Coventry is a WorkCompWire ad partner.
This is not a paid placement.